UK's bird flu vacc stocks "should rise 600%"

19 February 2007

With an outbreak of avian influenza in the UK's largest turkey farm, the government has been advised to massively increase antiviral drug stockpiling, but the British Medical Journal also reports on the potential of combination antiviral therapy as strategies for dealing with any future pandemic.

Computer modelling of a possible outbreak of the H5N1 strain of avian influenza has prompted the UK government's scientific advisers to propose a sixfold increase in the UK's antiviral drugs stockpile.

The findings are the result of work carried out by Neil Ferguson, of Imperial College, London, which shows that the impact of a possible pandemic caused by the mutation of the H5N1 avian flu virus into a virulent human-to-human transmitable disease, could be attenuated by treating those people most likely to be infected before symptoms appear.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight